Literature DB >> 15506933

RNA interference and double-stranded-RNA-activated pathways.

C A Sledz1, B R G Williams.   

Abstract

RNAi (RNA interference) has become a powerful tool to determine gene function. Different methods of expressing the short ds (double-stranded) RNA intermediates required for interference in mammalian systems have been developed, including the introduction of si (short interfering) RNAs by direct transfection or driven from transfected plasmids or lentiviral vectors encoding sh (short hairpin) RNAs. Although RNAi relies upon a high degree of specificity, recent findings suggest that off-target non-specific effects can be encountered. We found that transfection of siRNAs can results in an interferon-mediated activation of the JAK/STAT (Janus kinase/signal transducer and activator of transcription) pathway and global up-regulation of interferon-stimulated genes. This effect is mediated in part by the dsRNA-dependent protein kinase PKR, as this kinase is activated by the 21 bp siRNA, and is required in response to the siRNAs. However, the transcription factor IRF3 (interferon-regulatory factor 3) is also activated by siRNA as a primary response, resulting in the stimulation of genes independent of an interferon response. In cells deficient in IRF3, this response is blunted, but can be restored by re-introduction of IRF3. Thus siRNAs induce complex signalling responses in target cells, leading to effects beyond the selective silencing of specific genes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15506933     DOI: 10.1042/BST0320952

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  33 in total

Review 1.  Potential applications of intracellular antibodies (intrabodies) in stem cell therapeutics.

Authors:  Boon Chin Heng; David Michael Kemeny; Hua Liu; Tong Cao
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

Review 2.  Silence of the transcripts: RNA interference in medicine.

Authors:  Sailen Barik
Journal:  J Mol Med (Berl)       Date:  2005-07-19       Impact factor: 4.599

3.  Large-scale production of dsRNA and siRNA pools for RNA interference utilizing bacteriophage phi6 RNA-dependent RNA polymerase.

Authors:  Antti P Aalto; L Peter Sarin; Alberdina A van Dijk; Mart Saarma; Minna M Poranen; Urmas Arumäe; Dennis H Bamford
Journal:  RNA       Date:  2007-01-19       Impact factor: 4.942

4.  A model for the origin of protein synthesis as coreplicational scanning of nascent RNA.

Authors:  Alexander V Yakhnin
Journal:  Orig Life Evol Biosph       Date:  2007-09-20       Impact factor: 1.950

Review 5.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

6.  The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination.

Authors:  André Heinen; David Kremer; Peter Göttle; Fabian Kruse; Birgit Hasse; Helmar Lehmann; Hans Peter Hartung; Patrick Küry
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

7.  Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer.

Authors:  Natasa Anastasov; Margit Klier; Ina Koch; Daniela Angermeier; Heinz Höfler; Falko Fend; Leticia Quintanilla-Martinez
Journal:  J Hematop       Date:  2008-11-19       Impact factor: 0.196

Review 8.  Application of RNA interference in treating human diseases.

Authors:  S Abdolhamid Angaji; Sara Sadate Hedayati; Reihane Hosein Poor; Safoura Madani; Sanaz Samad Poor; Samin Panahi
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

Review 9.  Non-coding RNAs as drug targets.

Authors:  Masayuki Matsui; David R Corey
Journal:  Nat Rev Drug Discov       Date:  2016-07-22       Impact factor: 84.694

10.  Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunity.

Authors:  Dakang Xu; Michelle Holko; Anthony J Sadler; Bernadette Scott; Shigeki Higashiyama; Windy Berkofsky-Fessler; Melanie J McConnell; Pier Paolo Pandolfi; Jonathan D Licht; Bryan R G Williams
Journal:  Immunity       Date:  2009-06-11       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.